GO:0048208 COPII vesicle coat assembly: ER Export Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048208 COPII vesicle coat assembly describes the stepwise addition of COPII proteins and adaptor proteins to ER membranes to build a transport vesicle coat.
• The process is initiated by the small GTPase SAR1, which is activated by the guanine nucleotide exchange factor SEC12 and inserts into the ER membrane.
• The inner coat is formed by SEC23-SEC24 heterodimers that bind SAR1-GTP and recognize cargo export signals, while the outer coat is assembled from SEC13-SEC31 heterotetramers that polymerize into a cage.
• Combinatorial multivalent interactions among coat subunits drive cooperative assembly and cargo sorting, ensuring efficient ER-to-Golgi transport.
• Defects in COPII coat assembly are linked to human diseases including cranio-lenticulo-sutural dysplasia, congenital dyserythropoietic anemia type II, and various cancers.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential tools to dissect the causal roles of COPII genes in health and disease.
Description
COPII vesicle coat assembly (GO:0048208) is the biological process in which COPII proteins and adaptor proteins are added to the endoplasmic reticulum (ER) membrane to form a protein coat that drives the budding of transport vesicles. This process is the first and most selective step of the secretory pathway, enabling the export of newly synthesized proteins and lipids from the ER to the Golgi apparatus. The coat is not a static structure but a dynamic assembly of multiple subunits that work together to deform the membrane, capture cargo, and ultimately release a vesicle. Researchers study COPII vesicle coat assembly to understand fundamental mechanisms of intracellular trafficking, organelle homeostasis, and the molecular basis of diseases caused by trafficking defects. The process is highly conserved from yeast to humans, making it a powerful model for both basic cell biology and translational research.
COPII vesicle coat assembly At A Glance
| GO ID | GO:0048208 |
|---|---|
| GO term | COPII vesicle coat assembly |
| Ontology | biological_process |
| Synonym | COPII coating of ER-derived vesicle; COPII vesicle coat formation; COPII vesicle coating |
| Major function | Assembly of a protein coat on ER membranes to drive vesicle formation and selective cargo export |
| Key GTPase | SAR1 (SAR1A, SAR1B) |
| Inner coat subunits | SEC23-SEC24 heterodimers |
| Outer coat subunits | SEC13-SEC31 heterotetramers |
| Cellular location | Endoplasmic reticulum membrane and ER-derived vesicles |
What Is GO:0048208?
According to the Gene Ontology, COPII vesicle coat assembly (GO:0048208) is defined as the addition of COPII proteins and adaptor proteins to ER membranes during the formation of transport vesicles, forming a vesicle coat. In other words, it is the coordinated recruitment and polymerization of cytoplasmic COPII subunits onto the ER membrane surface, resulting in a curved protein cage that concentrates cargo and promotes membrane budding.
Why Is COPII vesicle coat assembly Important in Cell Biology?
COPII vesicle coat assembly is essential for the secretory pathway, as it governs the first step of protein export from the ER and thus influences the entire cellular proteome and lipidome. Defects in this process cause a range of human diseases, including skeletal dysplasias, anemias, and neurodegenerative conditions, and are increasingly implicated in cancer progression. Understanding the molecular details of coat assembly provides targets for therapeutic intervention and helps explain how cells maintain ER homeostasis under stress.
• COPII coat assembly is the rate-limiting step for ER-to-Golgi transport of secretory and membrane proteins.
• It ensures selective export of correctly folded cargo while retaining ER-resident proteins.
• Mutations in COPII genes cause cranio-lenticulo-sutural dysplasia and congenital dyserythropoietic anemia type II.
• Dysregulation of COPII components is observed in various cancers, including melanoma and pancreatic cancer.
• The process is hijacked by pathogens to facilitate their replication and spread.
• COPII coat assembly is a model system for studying membrane deformation and protein self-assembly.
• It is critical for the biogenesis of organelles such as the Golgi and for autophagy initiation.
• The process is regulated by post-translational modifications and interactions with tethering factors.
• Defects in COPII function are linked to neurodegeneration and ER stress-related disorders.
What Happens During COPII vesicle coat assembly?
Initiation by SAR1 GTPase
In simple terms: The process starts when a small protein called SAR1 is switched on and inserts into the ER membrane.
COPII vesicle coat assembly begins with the activation of the small GTPase SAR1 by the ER-localized guanine nucleotide exchange factor SEC12. Upon GTP binding, SAR1 undergoes a conformational change that exposes an amphipathic helix, allowing it to insert into the ER membrane and recruit the inner coat components. This step is essential for defining the site of vesicle formation and is tightly regulated by the nucleotide state of SAR1.
Inner coat assembly: SEC23-SEC24
In simple terms: SAR1 then recruits a pair of proteins called SEC23 and SEC24, which form the inner layer of the coat and grab cargo.
SAR1-GTP directly binds the SEC23-SEC24 heterodimer, which serves as the inner coat and adaptor complex. SEC24 recognizes specific export signals on cargo proteins, while SEC23 acts as a GTPase-activating protein (GAP) for SAR1, ensuring timely hydrolysis of GTP. This inner coat layer is responsible for cargo selection and concentration at the ER exit sites.
Outer coat assembly: SEC13-SEC31
In simple terms: The inner coat then recruits SEC13 and SEC31, which build an outer cage that shapes the vesicle.
The SEC13-SEC31 heterotetramer is recruited by the inner coat and polymerizes into a polyhedral cage that drives membrane curvature and vesicle budding. This outer coat assembly is cooperative and depends on multivalent interactions between SEC31 and the SEC23-SEC24 complex. The cage provides mechanical support and helps concentrate cargo while excluding non-cargo proteins.
Cargo recognition and sorting
In simple terms: The coat captures the right cargo proteins while leaving others behind.
Cargo recognition is mediated by SEC24, which binds to di-acidic (DXE) or di-hydrophobic motifs on transmembrane cargo proteins. Additional adaptor proteins, such as p125A (Sec23ip), couple coat assembly with donor-acceptor membrane organization to facilitate tunnel-based traffic. This selective sorting ensures that only properly folded and modified proteins are exported from the ER.
Membrane deformation and vesicle scission
In simple terms: The coat bends the membrane and eventually pinches off a vesicle.
As the coat assembles, it induces membrane curvature through the combined action of SAR1 insertion and the outer cage. The GTP hydrolysis by SAR1, stimulated by SEC23, leads to partial disassembly of the inner coat and promotes vesicle scission. The resulting COPII vesicle then uncoats and fuses with the Golgi, delivering its cargo.
Key Genes Involved in GO:0048208 COPII vesicle coat assembly
The following genes encode the core and accessory proteins that participate in COPII vesicle coat assembly, as established by biochemical and structural studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SAR1A | Small GTPase that initiates coat assembly | Knockout causes ER export defects; studied in cancer and secretion |
| SAR1B | Small GTPase paralog; mutations cause chylomicron retention disease | Disease modeling; lipid absorption studies |
| SEC23A | Inner coat subunit; GAP for SAR1; cargo adaptor | Mutations cause cranio-lenticulo-sutural dysplasia |
| SEC23B | Inner coat subunit; paralog of SEC23A | Mutations cause congenital dyserythropoietic anemia type II |
| SEC24A | Cargo receptor for specific export motifs | Knockout affects secretion of specific cargo |
| SEC24B | Cargo receptor; involved in planar cell polarity | Knockout causes neural tube defects in mice |
| SEC24C | Cargo receptor; broadly required for ER export | Essential for embryonic development |
| SEC24D | Cargo receptor; mutations cause Cole-Carpenter syndrome | Disease modeling; bone development |
| SEC13 | Outer coat subunit; forms cage with SEC31 | Knockout is lethal; role in nuclear pore complex |
| SEC31A | Outer coat subunit; polymerizes into cage | Knockout affects collagen secretion |
| SEC31B | Outer coat subunit; testis-specific paralog | Spermatogenesis studies |
| SEC12 | GEF for SAR1; initiates coat assembly | Overexpression activates COPII; ER stress studies |
| SEC16A | Scaffold protein at ER exit sites | Knockout disrupts ERES organization |
| SEC16B | Paralog of SEC16A; regulates ERES | Metabolic and secretion studies |
| p125A (SEC23IP) | Couples coat assembly with membrane organization | Knockout affects tunnel-based traffic |
| TFG | Tethering factor interacting with COPII | Mutations cause hereditary motor neuropathy |
| USO1 (p115) | Tethering factor for Golgi fusion | Knockout impairs ER-to-Golgi transport |
| BET1 | SNARE involved in Golgi fusion | Studies of vesicle fusion fidelity |
How Is COPII vesicle coat assembly Regulated?
COPII vesicle coat assembly is regulated at multiple levels. The nucleotide cycle of SAR1, controlled by SEC12 (GEF) and SEC23 (GAP), provides a timer for coat assembly and disassembly. Post-translational modifications, such as phosphorylation of SEC31 and SEC24, modulate coat dynamics in response to cellular signals. Additionally, the process is influenced by the availability of cargo and membrane lipids, and by interactions with tethering factors like p125A and TFG. ER stress and the unfolded protein response can also impact COPII function by altering the expression of coat components.
COPII vesicle coat assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SEC23A | Cranio-lenticulo-sutural dysplasia | Knock-in mouse with patient mutation; patient-derived iPSCs |
| SEC23B | Congenital dyserythropoietic anemia type II | Knockout erythroid cell lines; zebrafish models |
| SEC24D | Cole-Carpenter syndrome | Knock-in mice; osteoblast differentiation models |
| SAR1B | Chylomicron retention disease | Knockout intestinal cell lines; mouse models |
| TFG | Hereditary motor neuropathy | Knock-in mice; neuronal cell cultures |
COPII coat assembly in skeletal and connective tissue disorders
Mutations in SEC23A cause cranio-lenticulo-sutural dysplasia, characterized by skeletal abnormalities and facial dysmorphism, due to impaired collagen secretion. Similarly, mutations in SEC24D lead to Cole-Carpenter syndrome, a rare bone fragility disorder. These conditions highlight the critical role of COPII coat assembly in the secretion of extracellular matrix proteins.
COPII coat assembly in hematological disorders
Biallelic mutations in SEC23B are the primary cause of congenital dyserythropoietic anemia type II (CDAII), a rare red blood cell disorder. The disease is linked to defective ER-to-Golgi trafficking in erythroid precursors, leading to ineffective erythropoiesis. This underscores the importance of COPII function in specialized secretory cells.
COPII coat assembly in cancer
Altered expression of COPII components, including SAR1A, SEC23A, and SEC31A, has been observed in various cancers, where they can promote tumor growth and metastasis by enhancing secretion of pro-tumorigenic factors. Targeting COPII assembly is being explored as a potential therapeutic strategy in cancers with high secretory demand.
COPII coat assembly in neurodegeneration
Defects in COPII-mediated trafficking are implicated in neurodegenerative diseases such as hereditary motor neuropathy caused by TFG mutations, and in ER stress-related neuronal death. Proper COPII function is essential for neuronal survival and synaptic function.
From COPII vesicle coat assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of a COPII gene? | CRISPR knockout cell lines (e.g., HEK293T, HeLa) |
| How does a specific patient mutation affect coat assembly? | CRISPR point mutation knock-in (e.g., SEC23A p.Gly943Arg) |
| How does tagging a COPII protein affect its localization? | CRISPR knock-in of fluorescent tag (e.g., GFP-SEC31A) |
| What happens when a COPII gene is overexpressed? | CRISPR overexpression (e.g., SAR1A, SEC12) |
| Which cargo proteins are mis-secreted upon COPII dysfunction? | Secretome proteomics in knockout cells |
| Can a candidate gene rescue the knockout phenotype? | CRISPR knock-in of wild-type or mutant cDNA |
How to Study the COPII vesicle coat assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence microscopy | Dynamics of COPII coat assembly at ER exit sites | Real-time visualization of coat recruitment |
| Immunofluorescence | Co-localization of COPII subunits and cargo | Fixed-cell analysis of coat composition |
| Co-immunoprecipitation | Protein-protein interactions among COPII subunits | Mapping the assembly interactome |
| In vitro liposome binding | Direct binding of COPII proteins to membranes | Reconstitution of coat assembly |
| Mass spectrometry | Cargo and accessory proteins in COPII vesicles | Proteomic profiling of ER export |
| CRISPR knockout screening | Genes required for COPII-dependent transport | Identification of novel regulators |
| RNA-seq | Transcriptional changes upon COPII dysfunction | ER stress and UPR activation |
| Proximity labeling (BioID) | Spatial interactome of COPII components | Mapping dynamic interactions in cells |
Live-cell imaging of COPII dynamics
Fluorescently tagged COPII subunits (e.g., GFP-SEC31A, mCherry-SEC23A) can be visualized in living cells to track coat assembly at ER exit sites in real time. This method reveals the kinetics of coat recruitment and disassembly and is often combined with FRAP or photoactivation.
Proteomic analysis of COPII vesicles
Isolation of COPII vesicles followed by mass spectrometry identifies cargo and accessory proteins, providing a systems-level view of coat function. Quantitative proteomics can compare wild-type and mutant cells to uncover trafficking defects.
In vitro reconstitution of coat assembly
Purified COPII components and synthetic liposomes can be used to reconstitute coat assembly in vitro, allowing precise dissection of protein-protein and protein-lipid interactions. This approach has been instrumental in defining the minimal machinery for vesicle formation.
CRISPR screening for modifiers of COPII function
Genome-wide CRISPR knockout or activation screens can identify genes that modify COPII-dependent trafficking, using reporters of ER export or secretion. Such screens reveal novel regulators and potential therapeutic targets.
How CRISPR Can Be Used to Study GO:0048208 COPII vesicle coat assembly
Knockout
CRISPR knockout of COPII genes (e.g., SAR1A, SEC23A, SEC24D) in cell lines such as HEK293T or HeLa allows researchers to study the consequences of complete loss of function on ER-to-Golgi transport, cargo secretion, and cell viability. Knockout models are essential for identifying essential genes and for validating drug targets.
Point Mutation
CRISPR point mutation knock-in can introduce disease-associated mutations (e.g., SEC23A p.Gly943Arg, SEC23B p.Arg14Trp) into the endogenous locus, providing physiologically relevant models to study the molecular basis of cranio-lenticulo-sutural dysplasia and congenital dyserythropoietic anemia type II. These models are superior to overexpression systems for understanding mutant protein behavior.
Knock-in
CRISPR knock-in of fluorescent tags (e.g., GFP, mCherry) or epitope tags (e.g., HA, FLAG) into COPII genes enables real-time imaging and biochemical purification of coat complexes under native expression levels. Tagged knock-in models are invaluable for studying the spatiotemporal dynamics of coat assembly.
Overexpression
CRISPR-mediated overexpression (e.g., by inserting a strong promoter or using CRISPR activation) of COPII genes such as SAR1A or SEC12 can amplify coat assembly and secretion, allowing researchers to study gain-of-function effects and to produce high yields of secreted proteins. Overexpression models are also used to screen for dominant-negative phenotypes.
How EDITGENE Supports COPII vesicle coat assembly Research
Researchers studying COPII vesicle coat assembly-related genes often need to determine whether a candidate gene is causally involved in ER export, cargo sorting, or disease pathogenesis. Generating precise genetic models is the most reliable way to establish causality and to dissect molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR services tailored to COPII research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for COPII vesicle coat assembly research.
Frequently Asked Questions About COPII vesicle coat assembly
What is COPII vesicle coat assembly?
COPII vesicle coat assembly (GO:0048208) is the process by which COPII proteins and adaptor proteins are added to the ER membrane to form a vesicle coat that drives ER-to-Golgi transport.
What genes are involved in COPII vesicle coat assembly?
Key genes include SAR1A, SAR1B, SEC23A, SEC23B, SEC24A-D, SEC13, SEC31A, SEC31B, SEC12, SEC16A, and SEC16B, among others.
What is the function of COPII vesicles?
COPII vesicles transport newly synthesized proteins and lipids from the endoplasmic reticulum to the Golgi apparatus, and their coat assembly is essential for selective cargo export.
How is COPII coat assembly initiated?
It is initiated by the activation of SAR1 GTPase by SEC12, which inserts into the ER membrane and recruits the inner coat complex SEC23-SEC24.
What diseases are associated with COPII coat assembly defects?
Mutations in COPII genes cause cranio-lenticulo-sutural dysplasia, congenital dyserythropoietic anemia type II, Cole-Carpenter syndrome, and Chylomicron retention disease, and are implicated in cancer and neurodegeneration.
What is the difference between COPII and COPI coats?
COPII coats mediate anterograde transport from the ER to the Golgi, while COPI coats mediate retrograde transport from the Golgi to the ER and intra-Golgi transport.
How can I study COPII vesicle coat assembly in the lab?
Common methods include live-cell imaging of fluorescently tagged COPII subunits, in vitro reconstitution, proteomics of isolated vesicles, and CRISPR-based genetic screens.
What are the subunits of the COPII coat?
The COPII coat consists of an inner layer of SEC23-SEC24 heterodimers and an outer layer of SEC13-SEC31 heterotetramers, along with the GTPase SAR1.
Can CRISPR be used to model COPII-related diseases?
Yes, CRISPR knockout, point mutation knock-in, and tagged knock-in models are widely used to study COPII gene function and disease mechanisms.
What is the role of SAR1 in COPII assembly?
SAR1 is a small GTPase that, when activated by SEC12, inserts into the ER membrane and recruits the SEC23-SEC24 complex, thereby initiating coat assembly.
Conclusion
COPII vesicle coat assembly (GO:0048208) is a fundamental cellular process that governs the first step of the secretory pathway. Its precise regulation is essential for protein homeostasis, and its dysfunction leads to a spectrum of human diseases. Continued research using advanced CRISPR models and high-throughput methods will further illuminate the molecular details of coat assembly and open new avenues for therapeutic intervention.
References
- 1. Downes KW et al.. 2025. Mechanisms of COPII coat assembly and cargo recognition in the secretory pathway.. Nat Rev Mol Cell Biol 26(12):910-925 PMID: 40133632
- 2. Long KR et al.. 2025. p125A (Sec23ip) couples COPII coat assembly with donor-acceptor membrane organization to facilitate tunnel-based traffic.. bioRxiv PMID: 40463098
- 3. Béthune J et al.. 2018. Assembly of COPI and COPII Vesicular Coat Proteins on Membranes.. Annu Rev Biophys 47:63-83 PMID: 29345989
- 4. Gürkan C et al.. 2006. The COPII cage: unifying principles of vesicle coat assembly.. Nat Rev Mol Cell Biol 7(10):727-38 PMID: 16990852
- 5. Stancheva VG et al.. 2020. Combinatorial multivalent interactions drive cooperative assembly of the COPII coat.. J Cell Biol 219(11) PMID: 32997735
- 6. Sato K. 2004. COPII coat assembly and selective export from the endoplasmic reticulum.. J Biochem 136(6):755-60 PMID: 15671485
- 7. Bickford LC et al.. 2004. A structural view of the COPII vesicle coat.. Curr Opin Struct Biol 14(2):147-53 PMID: 15093828
